Cite
HARVARD Citation
Gleason, A. et al. (2022). Does the FDA‐approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?. Medical journal of Australia. 216 (4), pp. 172-174. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gleason, A. et al. (2022). Does the FDA‐approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?. Medical journal of Australia. 216 (4), pp. 172-174. [Online].